Serum miR-214 Serves as a Biomarker for Prodromal Parkinson’s Disease

Circulating microRNAs (miRNAs) have been proposed to be accessible biomarkers for Parkinson’s disease (PD). However, there is a lack of known miRNAs that can serve as biomarkers for prodromal PD (pPD). We previously identified that miR-31 and miR-214 were dysregulated in PD. The aim of this study wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lanting, Ren, Jingru, Pan, Chenxi, Li, Yuqian, Xu, Jianxia, Dong, Hui, Chen, Yong, Liu, Weiguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581655/
https://www.ncbi.nlm.nih.gov/pubmed/34776924
http://dx.doi.org/10.3389/fnagi.2021.700959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581655/
https://www.ncbi.nlm.nih.gov/pubmed/34776924
http://dx.doi.org/10.3389/fnagi.2021.700959

Ejemplares similares